Masarykova univerzita

Výpis publikací

česky | in English

Filtrování publikací

    2020

  1. FARKAŠ, Šimon, Pavel ŠIMARA, Daniela ŘEHÁKOVÁ, Lenka VEVERKOVÁ a Irena KOUTNÁ. Endothelial Progenitor Cells Produced From Human Pluripotent Stem Cells by a Synergistic Combination of Cytokines, Small Compounds, and Serum-Free Medium. Frontiers in Cell and Developmental Biology. Lausanne: Frontiers Media S.A., 2020, roč. 8, č. 309, s. 1-15. ISSN 2296-634X. doi:10.3389/fcell.2020.00309.
  2. TESAŘOVÁ, Lenka, Klára JAREŠOVÁ, Pavel ŠIMARA a Irena KOUTNÁ. Umbilical Cord-Derived Mesenchymal Stem Cells Are Able to Use bFGF Treatment and Represent a Superb Tool for Immunosuppressive Clinical Applications. International Journal of Molecular Sciences. Basel: Multidisciplinary Digital Publishing Institute, 2020, roč. 21, č. 15, s. 20-27, 27 s. ISSN 1422-0067. doi:10.3390/ijms21155366.
  3. ŠIMARA, Pavel, Viktor LUKJANOV, Pavel OTÁHAL a Irena KOUTNÁ. Virus-free production of CAR T-cells for the treatment of solid tumors. In CAR-TCR Europe Summit. 2020.
  4. 2019

  5. FARKAŠ, Šimon, Pavel ŠIMARA, Daniela ŘEHÁKOVÁ, Tereza SOURALOVÁ a Irena KOUTNÁ. Novel synergistic culturing approach for efficient and robust differentiation of human pluripotent stem cells into endothelial progenitors. In 8. ročník konference Stem Cells and Cell Therapy: From Research to Modern Clinical Applications. 2019.
  6. ŠALINGOVÁ, Barbara, Pavel ŠIMARA, Pavel MATULA, Lenka ZAJÍČKOVÁ, Petr SYNEK, Ondřej JAŠEK, Lenka VEVERKOVÁ, Miroslava SEDLÁČKOVÁ, Zuzana NICHTOVA a Irena KOUTNÁ. The Effect of Uncoated SPIONs on hiPSC-Differentiated Endothelial Cells. International Journal of Molecular Sciences. BASEL: Molecular Diversity Preservation International, 2019, roč. 20, č. 14, s. 1-16. ISSN 1661-6596. doi:10.3390/ijms20143536.
  7. ŠALINGOVÁ, Barbara, Pavel ŠIMARA, Pavel MATULA, Lenka ZAJÍČKOVÁ, Petr SYNEK, Ondřej JAŠEK, Lenka VEVERKOVÁ, Milena SEDLÁČKOVÁ, Zuzana NICHTOVA a Irena KOUTNÁ. The Effect of Uncoated SPIONs on hiPSC-Differentiated Endothelial Cells. International Journal of Molecular Sciences. Switzerland: Molecular Diversity Preservation International, 2019, roč. 20, č. 14, s. 1-14, 16 s. ISSN 1661-6596. doi:10.3390/ijms20143536.
  8. 2018

  9. ŠIMARA, Pavel, Lenka TESAŘOVÁ, Daniela ŘEHÁKOVÁ, Šimon FARKAŠ, Barbara ŠALINGOVÁ, Kateřina KUTÁLKOVÁ, Eva VAVREČKOVÁ, Pavel MATULA, Petr MATULA, Lenka VEVERKOVÁ a Irena KRONTORÁD KOUTNÁ. Reprogramming of Adult Peripheral Blood Cells into Human Induced Pluripotent Stem Cells as a Safe and Accessible Source of Endothelial Cells. Stem Cells and Development. Mary Ann Liebert, Inc. publishers, 2018, roč. 27, č. 1, s. 10-22. ISSN 1547-3287. doi:10.1089/scd.2017.0132.
  10. ŠIMARA, Pavel, Lenka TESAŘOVÁ, Daniela ŘEHÁKOVÁ, Šimon FARKAŠ, Barbara ŠALINGOVÁ, Kateřina KUTÁLKOVÁ, Eva VAVREČKOVÁ, Pavel MATULA, Petr MATULA a Irena KRONTORÁD KOUTNÁ. Reprogramming of peripheral blood cells into hiPSCs as a source of endothelial cells. In SY-Stem symposium 2018. 2018.
  11. SVOBODA, David, Tereza NEČASOVÁ, Lenka TESAŘOVÁ a Pavel ŠIMARA. Tubular Network Formation Process Using 3D Cellular Potts Model. In Gooya A., Goksel O., Oguz I., Burgos N. Simulation and Synthesis in Medical Imaging. LNCS 11037. Neuveden: Springer, 2018. s. 90-99. ISBN 978-3-030-00535-1. doi:10.1007/978-3-030-00536-8_10.
  12. 2017

  13. ŠIMARA, Pavel, Lenka TESAŘOVÁ, Daniela ŘEHÁKOVÁ, Pavel MATULA, Stanislav STEJSKAL, Aleš HAMPL a Irena KRONTORÁD KOUTNÁ. DNA double-strand breaks in human induced pluripotent stem cell reprogramming and long-term in vitro culturing. Stem Cell Research & Therapy. Springer Nature, 2017, roč. 8, č. 73, s. 1-13. ISSN 1757-6512. doi:10.1186/s13287-017-0522-5.
  14. TESAŘOVÁ, Lenka, Pavel ŠIMARA, Stanislav STEJSKAL a Irena KRONTORÁD KOUTNÁ. Hematopoietic developmental potential of human pluripotent stem cell lines is accompanied by the morphology of embryoid bodies and the expression of endodermal and hematopoietic markers. Cellular Reprogramming. 2017, roč. 19, č. 4, s. 270-284. ISSN 2152-4971. doi:10.1089/cell.2016.0042.
  15. ŠIMARA, Pavel, Irena KRONTORÁD KOUTNÁ, Lenka TESAŘOVÁ a Šimon FARKAŠ. POTENTIAL OF hiPSCs DERIVED FROM DIFFERENT CELL TYPES TO DIFFERENTIATE INTO FUNCTIONAL ENDOTHELIAL CELLS. In ISSCR 2017 Annual Meeting. 2017.
  16. 2016

  17. ŠIMARA, Pavel, Irena KRONTORÁD KOUTNÁ, Lenka TESAŘOVÁ, Daniela ŘEHÁKOVÁ a Pavel MATULA. DNA double strand breaks detection in pluripotent stem cells with regard to cell cycle stages. In ISSCR 2016 Annual Meeting. 2016.
  18. ŠIMARA, Pavel, Lenka TESAŘOVÁ, Daniela ŘEHÁKOVÁ, Pavel MATULA a Irena KRONTORÁD KOUTNÁ. Genomic Stability of the Cells during hiPSC Reprogramming and Endothelial Differentiation. In 12th International Congress of Cell Biology. 2016.
  19. ŠALINGOVÁ, Barbara, Pavel ŠIMARA, Petr SYNEK, Lenka ZAJÍČKOVÁ, Zuzana NICHTOVÁ a Irena KRONTORÁD KOUTNÁ. Paramagnetic nanoparticles in stem cell therapy. In Bioimplantologie. 2016.
  20. TESAŘOVÁ, Lenka, Pavel ŠIMARA, Stanislav STEJSKAL a Irena KRONTORÁD KOUTNÁ. The Aberrant DNA Methylation Profile of Human Induced Pluripotent Stem Cells Is Connected to the Reprogramming Process and Is Normalized During In Vitro Culture. PLOS ONE. Public Library of Science, 2016, roč. 11, č. 6, s. nestránkováno, 16 s. ISSN 1932-6203. doi:10.1371/journal.pone.0157974.
  21. KRATOCHVÍLOVÁ, Kateřina, Lukáš MORÁŇ, Stanislava PAĎOUROVÁ, Stanislav STEJSKAL, Lenka TESAŘOVÁ, Pavel ŠIMARA, Aleš HAMPL, Irena KRONTORÁD KOUTNÁ a Petr VAŇHARA. The role of the endoplasmic reticulum stress in stemness, pluripotency and development. European Journal of Cell Biology. Jena: Elsevier GMBH, 2016, roč. 95, 3-5, s. 115-123. ISSN 0171-9335. doi:10.1016/j.ejcb.2016.02.002.
  22. 2015

  23. STEJSKAL, Stanislav, Karel ŠTĚPKA, Lenka TESAŘOVÁ, Karel STEJSKAL, Martina MATĚJKOVÁ, Pavel ŠIMARA, Zbyněk ZDRÁHAL a Irena KRONTORÁD KOUTNÁ. Cell cycle-dependent changes in H3K56ac in human cells. Cell Cycle. Philadelphia: Taylor&Francis Inc, 2015, roč. 14, č. 24, s. 3851-3863. ISSN 1538-4101. doi:10.1080/15384101.2015.1106760.
  24. KRONTORÁD KOUTNÁ, Irena, Pavel ŠIMARA, Pavel MATULA, Lenka TESAŘOVÁ a Barbara ŠALINGOVÁ. Derivation of human induced pluripotent stem cells and Advanced Methods of Image Processing. In CEITEC PhD Retreat, 23-24.4.2015, Valtice Czech Republic. 2015.
  25. TESAŘOVÁ, Lenka, Barbara ŠALINGOVÁ, Pavel ŠIMARA a Irena KRONTORÁD KOUTNÁ. Hematopoietic developmental potential is variable in pluripotent stem cell lines. In Conference Frontiers in Material and Life Sciences: Creating Life in 3D, 2-4 September, 2015, Brno. 2015.
  26. SOROKIN, Dmitry, Lenka STIXOVÁ, Petra SEHNALOVÁ, Soňa LEGARTOVÁ, Jana SUCHÁNKOVÁ, Pavel ŠIMARA, Stanislav KOZUBEK, Pavel MATULA, Magdalena SKALNÍKOVÁ, Ivan RAŠKA a Eva BÁRTOVÁ. Localized movement and morphology of UBF1-positive nucleolar regions are changed by gamma-irradiation in G2 phase of the cell cycle. Nucleus. 2015, roč. 6, č. 4, s. 301-313. ISSN 1949-1034. doi:10.1080/19491034.2015.1075111.
  27. TESAŘOVÁ, Lenka, Pavel ŠIMARA, Stanislav STEJSKAL a Irena KRONTORÁD KOUTNÁ. Pluripotent stem cell lines display variable hematopoietic developmental potential. In 2015 EMBL Symposium: Frontiers in Stem Cells & Cancer, Heidelberg, Germany, Mar 29-31, 2015. 2015.
  28. STEJSKAL, Stanislav, Bára SZAROWSKÁ, Lenka TESAŘOVÁ, Pavel ŠIMARA a Irena KRONTORÁD KOUTNÁ. Single-cell analysis of long-range interactions of POU5F1 foci in hESC cells. In EMBL konference: Frontiers in Stec Cells and Cancer. 2015.
  29. ŠIMARA, Pavel, Irena KRONTORÁD KOUTNÁ, Stanislav STEJSKAL a Lenka TESAŘOVÁ. The effect of reprogramming method, source cell type and long-term cell culture on genomic stability of human induced pluripotent stem cells. In ISSCR 2015 Annual Meeting. 2015.
  30. 2014

  31. POTĚŠIL, David, Stanislav STEJSKAL, Marek BORSKÝ, Pavel ŠIMARA, Martina HAVELKOVÁ, Filip RÁZGA, Irena KRONTORÁD KOUTNÁ, Dana DVOŘÁKOVÁ, Jiří MAYER, Zdeněk RÁČIL a Zbyněk ZDRÁHAL. Determination of Imatinib in the Blood Cells of Chronic Myelogenous Leukemia Patients by Ion-Trap Mass Spectrometry. Analytical Letters. PHILADELPHIA: TAYLOR & FRANCIS INC, 2014, roč. 47, č. 6, s. 944-957. ISSN 0003-2719. doi:10.1080/00032719.2013.860538.
  32. TESAŘOVÁ, Lenka, Pavel ŠIMARA, Stanislav STEJSKAL a Irena KRONTORÁD KOUTNÁ. DNA methylation levels of selected genes in human pluripotent stem cell lines intended for hematopoietic differentiation. In 2014 EMBO Conference Stem Cells in Cancer and Regenerative medicine, Heidelberg, Germany, Oct 9-12, 2014. 2014.
  33. ŠALINGOVÁ, Barbara, Martina MADARÁSOVÁ, Stanislav STEJSKAL, Lenka TESAŘOVÁ, Pavel ŠIMARA a Irena KRONTORÁD KOUTNÁ. From Endothelial Progenitor Cells to Tissue Engineering: How Far Have We Come? Journal of Stem Cell Research & Therapy. 5716 Corsa Ave, Los Angeles, USA: OMICS group, 2014, roč. 4, č. 3, s. 185-195. ISSN 2157-7633. doi:10.4172/2157-7633.1000185.
  34. ŠIMARA, Pavel, Lenka TESAŘOVÁ, Stanislava PAĎOUROVÁ a Irena KRONTORÁD KOUTNÁ. Generation of Human Induced Pluripotent Stem Cells Using Genome Integrating or Non-integrating Methods. In Advances in Molecular and Cancer Biology. 2014.
  35. ŠIMARA, Pavel, Lenka TESAŘOVÁ, Stanislava PAĎOUROVÁ a Irena KRONTORÁD KOUTNÁ. Generation of Human Induced Pluripotent Stem Cells Using Genome Integrating or Non-integrating Methods. Folia Biologica. Praha: Univerzita Karlova, 2014, roč. 60, S1, s. 85-89. ISSN 0015-5500.
  36. TESAŘOVÁ, Lenka, Pavel ŠIMARA, Stanislav STEJSKAL a Irena KRONTORÁD KOUTNÁ. Haematopoietic developmental potential of human pluripotent stem cell lines. Folia biologica. Praha: Univerzita Karlova, 2014, roč. 60, č. 1, s. 90-94. ISSN 0015-5500.
  37. TESAŘOVÁ, Lenka, Pavel ŠIMARA, Barbara ŠALINGOVÁ a Irena KRONTORÁD KOUTNÁ. Hematopoietic differentiation of human pluripotent stem cells. In Advances in Molecular and Cancer Biology. 2014.
  38. RUČKA, Zdeněk, Irena KRONTORÁD KOUTNÁ, Lenka TESAŘOVÁ, Michaela POTĚŠILOVÁ, Stanislav STEJSKAL, Pavel ŠIMARA, Petr VAŇHARA, Jan DOLEŽEL, Václav ZVONÍČEK, Oldřich COUFAL a Ivan ČAPOV. Intravenous insulin therapy during lung resection does not affect lung function or surfactant proteins. BMC Pulmonary Medicine. London, United Kingdom: BIOMED CENTRAL LTD, 2014, roč. 14, č. 1, s. 155-163. ISSN 1471-2466. doi:10.1186/1471-2466-14-155.
  39. 2013

  40. ŠIMARA, Pavel, Stanislav STEJSKAL, Irena KRONTORÁD KOUTNÁ, David POTĚŠIL, Lenka TESAŘOVÁ, Michaela POTĚŠILOVÁ, Zbyněk ZDRÁHAL a Jiří MAYER. Apoptosis in chronic myeloid leukemia cells transiently treated with imatinib or dasatinib is caused by residual BCR-ABL kinase inhibition. American Journal of Hematology. NJ 07030-577 United States: John Wiley & Sons, 2013, roč. 88, č. 5, s. 385-393. ISSN 0361-8609. doi:10.1002/ajh.23419.
  41. STEJSKAL, Stanislav, Martina MATĚJKOVÁ, Karel ŠTĚPKA, Michaela POTĚŠILOVÁ, Lenka TESAŘOVÁ, Pavel ŠIMARA a Irena KRONTORÁD KOUTNÁ. Cell cycle dependent changes of H3K56ac levels in cancer and hES cells. In 2013 IMB Conference: Chromatin Dynamics and Stem Cells. 2013.
  42. RUČKA, Zdeněk, Petr VAŇHARA, Irena KRONTORÁD KOUTNÁ, Lenka TESAŘOVÁ, Michaela POTĚŠILOVÁ, Stanislav STEJSKAL, Pavel ŠIMARA, Jan DOLEŽEL, Václav ZVONÍČEK, Oldřich COUFAL a Ivan ČAPOV. Differential effects of insulin and dexamethasone on pulmonary surfactant-associated genes and proteins in A549 and H441 cells and lung tissue. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. UNITED STATES: SPANDIDOS PUBL LTD, 2013, roč. 32, č. 1, s. 211-218. ISSN 1107-3756. doi:10.3892/ijmm.2013.1363.
  43. TESAŘOVÁ, Lenka, Irena KRONTORÁD KOUTNÁ, Alena DRDÚLOVÁ, Stanislav STEJSKAL, Michaela POTĚŠILOVÁ a Pavel ŠIMARA. In vitro developmental potential of human embryonic stem cell lines evaluated by gene expression analysis of a new set of differentiation markers. In 2013 ISSCR’s Stem Cell in Translation, Florence, Italy, Sept 15-18. 2013.
  44. ŠIMARA, Pavel, Jason MOTL a Dan KAUFMAN. Pluripotent stem cells and gene therapy. Translational Research. 2013, roč. 161, č. 4, s. 284-292. ISSN 1931-5244. doi:10.1016/j.trsl.2013.01.001.
  45. 2012

  46. ŠIMARA, Pavel, Stanislav STEJSKAL, Irena KRONTORÁD KOUTNÁ, David POTĚŠIL, Lenka TESAŘOVÁ, Michaela POTĚŠILOVÁ, Zbyněk ZDRÁHAL a Jiří MAYER. Apoptosis in Chronic Myeloid Leukemia Cells Transiently Treated with Imatinib or Dasatinib Is Caused by Residual BCR-ABL Kinase Inhibition. In 54th ASH Annual Meeting and Exposition. 2012. ISSN 1528-0020.
  47. ŠIMARA, Pavel, Martina PETERKOVÁ, Stanislav STEJSKAL, Michaela POTĚŠILOVÁ, Irena KRONTORÁD KOUTNÁ, Zdeněk RÁČIL, Filip RÁZGA, Tomáš JURČEK, Dana DVOŘÁKOVÁ a Jiří MAYER. BCR-ABL activity measured by 50% inhibitory concentration for imatinib, p-CrkL/CrkL ratio or p-CrkL ratio in CD34+ cells of patients with chronic myeloid leukemia does not predict treatment response. Leukemia & lymphoma. England: Informa Healthcare, 2012, roč. 53, č. 8, s. 1627-1629. ISSN 1042-8194. doi:10.3109/10428194.2012.656104.
  48. KRONTORÁD KOUTNÁ, Irena, Pavel ŠIMARA, Petra ONDRÁČKOVÁ a Lenka TESAŘOVÁ. Flow Cytometry Analysis of Intracelular Protein. In Ingrid Schmid, University of California, Los Angeles. Flow Cytometry , Recent Perspectives. Rijeka, Croatia: InTech, 2012. s. 421-438. Open science/open minds. ISBN 978-953-51-0626-5. doi:10.5772/38400.
  49. 2011

  50. KRONTORÁD KOUTNÁ, Irena, Martina PETERKOVÁ, Pavel ŠIMARA, Stanislav STEJSKAL, Lenka TESAŘOVÁ a Michal KOZUBEK. Proliferation and differentiation potential of CD133+ and CD34+ populations from the bone marrow and mobilized peripheral blood. Annals of hematology. Germany: Springer, 2011, roč. 90, (2), s. 127-137. ISSN 0939-5555.
  51. PELLICANO, Francesca, Pavel ŠIMARA, Amy SINCLAIR, Gudmundur Vignir HELGASON, Mhairi COPLAND, Steven GRANT a Tessa HOLYOAKE. The MEK inhibitor PD184352 enhances BMS-214662-induced apoptosis in CD34+ CML stem/progenitor cells. Leukemia. London: Nature Publishing Group, 2011, roč. 25, č. 7, s. 1159-1167. ISSN 0887-6924. doi:10.1038/leu.2011.67.
  52. 2010

  53. ŠIMARA, Pavel, Stanislav STEJSKAL, Martina PETERKOVÁ, Irena KRONTORÁD KOUTNÁ, Zdeněk RÁČIL a Jiří MAYER. Dasatinib Promotes BIM Dependent Apoptosis Via MEK/ERK without Need for Permanent BCR-ABL Inhibition. In ASH 2010. 2010. ISSN 1528-0020.
  54. ŠIMARA, Pavel, Stanislav STEJSKAL, Martina PETERKOVÁ, Jiří MAYER, Zdeněk RÁČIL, Irena KRONTORÁD KOUTNÁ a Michal KOZUBEK. Dasatinib suppresses MEK/ERK pathway activity without sustained BCR-ABL inhibition and promotes BIM dependent apoptosis in chronic myeloid leukaemia cells. In XXIV. Olomoucké hematologické dny s mezinárodní účastí. 2010. ISSN 1213-5763.
  55. ŠIMARA, Pavel, Stanislav STEJSKAL, Martina PETERKOVÁ, Irena KRONTORÁD KOUTNÁ, Zdeněk RÁČIL a Jiří MAYER. Determination of pCrkL level in chronic myeloid leukaemia cells using flow cytometry. In Advances in Molecular and Cancer Biology, 2010. Brno, Česká Republika: muni PRESS, 2010. s. 43-45. ISBN 978-80-210-5312-0.
  56. POTĚŠIL, David, Filip RÁZGA, Stanislav STEJSKAL, Lenka TESAŘOVÁ, Pavel ŠIMARA, Martina PETERKOVÁ, Dana DVOŘÁKOVÁ, Ludmila MALÁŠKOVÁ, Irena KRONTORÁD KOUTNÁ, Zdeněk RÁČIL, Jiří MAYER a Zbyněk ZDRÁHAL. Stanovení intracelulární koncentrace imatinibu u CML pacientů. 2010. ISSN 1213-5763.
  57. 2009

  58. ŠIMARA, Pavel, Irena KOUTNÁ, Stanislav STEJSKAL, Petr KRONTORÁD, Zdeněk RUČKA, Martina PETERKOVÁ a Michal KOZUBEK. Combination of mRNA and protein microarray analysis in complex cell profiling. Neoplasma. Bratislava, Slovensko: AEPress, s.r.o., 2009, roč. 2/2009, č. 56, s. 141-149. ISSN 0028-2685.
  59. ŠIMARA, Pavel, Steven GRANT, Tessa HOLYOAKE a Francesca PELLICANO. MEK inhibition enhances BMS-214662-induced apoptosis in primitive CD34+ CML stem/progenitor cells. In ESH: CHRONIC MYELOID LEUKEMIA - Biological Basis of Therapy. 2009.
  60. PETERKOVÁ, Martina, Irena KOUTNÁ, Pavel ŠIMARA, Stanislav STEJSKAL a Lenka TESAŘOVÁ. The in vitro proliferation potential and proportion of CD133+ versus CD34+ hematopoietic stem cells. In Experimental Hematology, Volume 37, Number 9. University of Nevada, USA: Elsevier, 2009. s. 35-36. ISSN 0301-472X.
  61. 2007

  62. ŠIMARA, Pavel, Irena KOUTNÁ, Stanislav STEJSKAL, Martina PETERKOVÁ, Petr KRONTORÁD a Zdeněk RUČKA. Large-scale Microarray Analysis of Protein and mRNA Level Changes in HL-60 Cells. 2007.
Zobrazit podrobně
Zobrazeno: 15. 4. 2021 02:12